51/120
2.1 / 5 stars
All 120 Win/Lose results shown below
CLPT Roast Me summary
ClearPoint Neuro, Inc. (CLPT). Every strict quarterly win earns 1 point. A loss, tie, or unavailable scoring value earns 0.
- 2026-Q2: Total return Win; Revenue growth Win; EPS growth Lose.
- 2026-Q1: Total return Lose; Revenue growth Win; EPS growth Lose.
- 2025-Q4: Total return Lose; Revenue growth Win; EPS growth Lose.
- 2025-Q3: Total return Win; Revenue growth Win; EPS growth Lose.
Trailing 1 year (4 quarters): 6 wins, 6 lossesLast fetched: 25 Sept 2026
Complete point ledger
Each cell identifies the missing side explicitly.
| Quarter | Total return | Revenue growth | EPS growth |
|---|---|---|---|
| 2026-Q22/3 |
WinCLPT / S&P 96.04% / 15.20% |
WinCLPT / S&P 25.86% / 15.00% |
LoseCLPT / S&P CLPT unavailable / 50.40% |
| 2026-Q11/3 |
LoseCLPT / S&P -33.48% / -4.33% |
WinCLPT / S&P 25.99% / 11.30% |
LoseCLPT / S&P CLPT unavailable / 27.70% |
| 2025-Q41/3 |
LoseCLPT / S&P -37.22% / 2.65% |
WinCLPT / S&P 17.78% / 9.00% |
LoseCLPT / S&P CLPT unavailable / 13.40% |
| 2025-Q32/3 |
WinCLPT / S&P 82.50% / 8.12% |
WinCLPT / S&P 12.83% / 4.61% |
LoseCLPT / S&P CLPT unavailable / 13.45% |
| 2025-Q21/3 |
LoseCLPT / S&P 0.42% / 10.94% |
WinCLPT / S&P 19.68% / 4.83% |
LoseCLPT / S&P CLPT unavailable / 10.63% |
| 2025-Q11/3 |
LoseCLPT / S&P -22.69% / -4.27% |
WinCLPT / S&P 23.22% / 4.98% |
LoseCLPT / S&P CLPT unavailable / 10.57% |
| 2024-Q42/3 |
WinCLPT / S&P 37.20% / 2.41% |
WinCLPT / S&P 31.04% / 5.25% |
LoseCLPT / S&P CLPT unavailable / 6.15% |
| 2024-Q32/3 |
WinCLPT / S&P 107.98% / 5.89% |
WinCLPT / S&P 36.34% / 5.89% |
LoseCLPT / S&P CLPT unavailable / 6.11% |
| 2024-Q21/3 |
LoseCLPT / S&P -20.74% / 4.28% |
WinCLPT / S&P 29.33% / 5.38% |
LoseCLPT / S&P CLPT unavailable / 5.12% |
| 2024-Q11/3 |
LoseCLPT / S&P 0.15% / 10.56% |
WinCLPT / S&P 24.86% / 5.71% |
LoseCLPT / S&P CLPT unavailable / 5.59% |
| 2023-Q42/3 |
WinCLPT / S&P 35.53% / 11.69% |
WinCLPT / S&P 16.56% / 6.81% |
LoseCLPT / S&P CLPT unavailable / 7.78% |
| 2023-Q31/3 |
LoseCLPT / S&P -30.80% / -3.27% |
WinCLPT / S&P 13.53% / 7.52% |
LoseCLPT / S&P CLPT unavailable / -5.03% |
| 2023-Q21/3 |
LoseCLPT / S&P -14.22% / 8.74% |
WinCLPT / S&P 13.71% / 9.50% |
LoseCLPT / S&P CLPT unavailable / -8.57% |
| 2023-Q11/3 |
LoseCLPT / S&P -0.35% / 7.50% |
WinCLPT / S&P 21.12% / 10.77% |
LoseCLPT / S&P CLPT unavailable / -15.69% |
| 2022-Q41/3 |
LoseCLPT / S&P -18.24% / 7.56% |
WinCLPT / S&P 26.09% / 11.88% |
LoseCLPT / S&P CLPT unavailable / -17.99% |
| 2022-Q31/3 |
LoseCLPT / S&P -20.61% / -4.88% |
WinCLPT / S&P 24.95% / 13.47% |
LoseCLPT / S&P CLPT unavailable / -1.41% |
| 2022-Q22/3 |
WinCLPT / S&P 25.36% / -16.10% |
WinCLPT / S&P 30.04% / 13.71% |
LoseCLPT / S&P CLPT unavailable / 11.04% |
| 2022-Q11/3 |
LoseCLPT / S&P -7.22% / -4.60% |
WinCLPT / S&P 25.88% / 15.97% |
LoseCLPT / S&P CLPT unavailable / 42.23% |
| 2021-Q41/3 |
LoseCLPT / S&P -36.79% / 11.03% |
WinCLPT / S&P 27.05% / 15.00% |
LoseCLPT / S&P CLPT unavailable / 96.40% |
| 2021-Q31/3 |
LoseCLPT / S&P -7.02% / 0.58% |
WinCLPT / S&P 27.67% / 10.77% |
LoseCLPT / S&P CLPT unavailable / 69.42% |
| 2021-Q21/3 |
LoseCLPT / S&P -9.70% / 8.55% |
WinCLPT / S&P 25.11% / 6.58% |
LoseCLPT / S&P CLPT unavailable / 51.81% |
| 2021-Q12/3 |
WinCLPT / S&P 33.04% / 6.17% |
WinCLPT / S&P 15.87% / -1.06% |
LoseCLPT / S&P CLPT unavailable / 7.39% |
| 2020-Q42/3 |
WinCLPT / S&P 191.03% / 12.15% |
WinCLPT / S&P 14.37% / -3.72% |
LoseCLPT / S&P CLPT unavailable / -33.42% |
| 2020-Q32/3 |
WinCLPT / S&P 53.37% / 8.93% |
WinCLPT / S&P 19.85% / -2.04% |
LoseCLPT / S&P CLPT unavailable / -27.10% |
| 2020-Q21/3 |
LoseCLPT / S&P -0.56% / 20.54% |
WinCLPT / S&P 28.04% / -0.46% |
LoseCLPT / S&P CLPT unavailable / -27.11% |
| 2020-Q11/3 |
LoseCLPT / S&P -25.42% / -19.60% |
WinCLPT / S&P 44.60% / 3.47% |
LoseCLPT / S&P CLPT unavailable / -14.75% |
| 2019-Q41/3 |
LoseCLPT / S&P -5.14% / 9.07% |
WinCLPT / S&P 52.54% / 5.36% |
LoseCLPT / S&P CLPT unavailable / 2.99% |
| 2019-Q32/3 |
WinCLPT / S&P 58.12% / 1.70% |
WinCLPT / S&P 52.20% / 5.02% |
LoseCLPT / S&P CLPT unavailable / 0.21% |
| 2019-Q21/3 |
LoseCLPT / S&P 0.00% / 4.30% |
WinCLPT / S&P 37.45% / 6.64% |
LoseCLPT / S&P CLPT unavailable / 8.65% |
| 2019-Q12/3 |
WinCLPT / S&P 103.82% / 13.65% |
WinCLPT / S&P 17.25% / 8.12% |
LoseCLPT / S&P CLPT unavailable / 14.29% |
| 2018-Q40/3 |
LoseCLPT / S&P -21.50% / -13.52% |
LoseCLPT / S&P -0.36% / 9.05% |
LoseCLPT / S&P CLPT unavailable / 18.23% |
| 2018-Q30/3 |
LoseCLPT / S&P -6.98% / 7.71% |
LoseCLPT / S&P -7.90% / 10.21% |
LoseCLPT / S&P CLPT unavailable / 19.06% |
| 2018-Q20/3 |
LoseCLPT / S&P -34.85% / 3.43% |
LoseCLPT / S&P -7.86% / 9.03% |
LoseCLPT / S&P CLPT unavailable / 14.46% |
| 2018-Q12/3 |
WinCLPT / S&P 20.00% / -0.76% |
WinCLPT / S&P 9.96% / 7.68% |
LoseCLPT / S&P CLPT unavailable / 12.46% |
| 2017-Q42/3 |
WinCLPT / S&P 14.58% / 6.64% |
WinCLPT / S&P 28.35% / 7.03% |
LoseCLPT / S&P CLPT unavailable / 13.82% |
| 2017-Q31/3 |
LoseCLPT / S&P -35.14% / 4.48% |
WinCLPT / S&P 30.38% / 5.68% |
LoseCLPT / S&P CLPT unavailable / 17.57% |
| 2017-Q21/3 |
LoseCLPT / S&P -26.00% / 3.09% |
WinCLPT / S&P 37.64% / 4.83% |
LoseCLPT / S&P CLPT unavailable / 17.74% |
| 2017-Q12/3 |
WinCLPT / S&P 47.06% / 6.07% |
WinCLPT / S&P 27.81% / 3.67% |
LoseCLPT / S&P CLPT unavailable / 13.32% |
| 2016-Q41/3 |
LoseCLPT / S&P -43.71% / 3.82% |
WinCLPT / S&P 25.15% / 2.09% |
LoseCLPT / S&P CLPT unavailable / 7.05% |
| 2016-Q31/3 |
LoseCLPT / S&P -34.35% / 3.85% |
WinCLPT / S&P 39.17% / 0.20% |
LoseCLPT / S&P CLPT unavailable / -3.15% |
Dividend-reinvested, split-adjusted total return
1Y · 2025-08-29 to 2026-08-28
| Metric | CLPT total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | 48.38% | 20.78% |
| Annualized return | 48.38% | 20.78% |
5Y · 2021-09-01 to 2026-08-28
| Metric | CLPT total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -20.06% | 83.14% |
| Annualized return | -4.38% | 12.86% |
10Y · 2016-09-01 to 2026-08-28
| Metric | CLPT total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | 157.27% | 319.30% |
| Annualized return | 9.91% | 15.41% |
Calculation rules
- window
- Latest 40 completed benchmark quarters; unavailable issuer evidence remains visible and scores 0.
- return Basis
- Issuer adjusted close reinvests distributions and normalizes splits; the S&P 500 Total Return Index is the direct benchmark.
- point Rule
- Strict same-quarter win = 1. Loss, tie or unavailable evidence = 0. No partial or subjective points.
- frequency
- Quarter endpoints only.
- fundamentals
- Trailing-four-quarter issuer revenue and EPS growth use the issuer's normalized government-filed facts.
- non Scoring
Snapshot captured 2026-09-25.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sight Sciences, Inc. (SGHT) | United States | $0.478B | -9.95 |
| NeuroPace Inc (NPCE) | United States | $0.480B | -28.52 |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| Orthofix Medical Inc. (OFIX) | $0.373B | ||
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |
| CERUS CORP (CERS) | United States | $0.525B | -86.40 |
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |